Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

Company Overview

Development Stage

  • Stage: B+轮, 3亿人民币。

About the Company

[Summary] 生物医药技术及相关产品研发商

公司以解决肿瘤病患问题为主旨,重点开拓肿瘤新药研发领域,在肿瘤靶向性药物递送系统研发方面处于国际的水平;团队在该领域的研究和应用开发领域经验丰富,在研产品形成梯队并形成平台技术,优先改造疗效明确、存在毒性问题或代谢缺陷、且与PD1具有协同作用的药物,强调差异化的新药研发,进度快的产品已获准进入临床。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

亚飞生物 Financing History (7 rounds)

Manage
B+轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 3亿人民币
  • Investor: 国生资本,兰馨亚洲,鸿富资...

亚飞生物 Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 1,404.7315万(元)
Legal Representative: CHENG LIU(刘辰)
Date Established:
Credit Code: 91310115596437333T
Registered Address: 中国(上海)自由贸易试验区张江路368号29幢7层

People who follow 亚飞生物 also follow

亚飞生物 Competitors (Similar Companies)

医药 抗体 生物医药 抗肿瘤药
代理分销 采购代理 供应商
“In the rapidly growing biopharmaceutical field, accelerate and transfo”
抗肿瘤药 手术用药 造影剂 临床试验
“A high-tech enterprise specializing in drug development technical serv”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates